HALOZYME THERAPEUTICS INC (HALO)
US40637H1095 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to HALO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 59.05. This target is 5.01% above the current price.
HALO was analyzed by 17 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about HALO.
In the previous month the buy percentage consensus was at a similar level.
HALO was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-25 | Benchmark | Maintains | Buy -> Buy |
| 2024-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-06-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-06-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-16 | Benchmark | Reiterate | Buy -> Buy |
| 2024-02-29 | TD Cowen | Initiate | Outperform |
| 2024-02-21 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-02-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-19 | Benchmark | Reiterate | Buy -> Buy |
| 2024-01-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-01-18 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-26 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-20 | Benchmark | Reiterate | Buy -> Buy |
| 2023-10-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |